Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | KDM4A | O75164 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | CTSD | P07339 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7897984 | 1.00 | MAOB (0.47) | MAOBALDH1A1HTTTSHRKMT2A | |
| SCHEMBL23525317 | 0.87 | ALDH1A1 (0.49) | MAOBALDH1A1HTTTSHRKMT2A | |
| SCHEMBL1057910 | 0.86 | KMT2A (0.51) | MAOBALDH1A1HTTTSHRKMT2A | |
| SCHEMBL7897989 | 0.85 | ALDH1A1 (0.46) | MAOBALDH1A1HTTTSHRKMT2A | |
| SCHEMBL7897985 | 0.85 | ALDH1A1 (0.46) | MAOBALDH1A1HTTTSHRKMT2A | |
| SCHEMBL12869704 | 0.84 | KDM4A (0.49) | MAOBALDH1A1HTTTSHRKDM4A | |
| SCHEMBL12869702 | 0.84 | MAOB (0.48) | MAOBALDH1A1HTTTSHRKMT2A | |
| SCHEMBL6865970 | 0.83 | MAOB (0.52) | MAOBALDH1A1HTTTSHRKMT2A | |
| SCHEMBL7865835 | 0.82 | KDM4A (0.47) | MAOBALDH1A1HTTTSHRKDM4A | |
| SCHEMBL28393254 | 0.82 | KDM4A (0.47) | MAOBALDH1A1HTTTSHRKDM4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090181858-A1 | Adding photoregulated amino acids to the genetic code | THE SCRIPPS RESEARCH INSTITUTE (US) | 2009-07-16 | — | — | US | claimed |
| EP-1797177-A4 | ADDING PHOTOREGULATED AMINO ACIDS TO THE GENETIC CODE | SCRIPPS RESEARCH INST (US) | 2008-07-09 | — | — | EP | claimed |
| EP-1797177-A2 | ADDING PHOTOREGULATED AMINO ACIDS TO THE GENETIC CODE | The Scripps Research Institute (US) | 2007-06-20 | — | — | EP | claimed |
| US-20060134746-A1 | Adding photoregulated amino acids to the genetic code | THE SCRIPPS RESEARCH INSTITUTE (US) | 2006-06-22 | — | — | US | claimed |
| WO-2006034410-A2 | ADDING PHOTOREGULATED AMINO ACIDS TO THE GENETIC CODE | THE SCRIPPS RESARCH INSTITUTE (US) | 2006-03-30 | — | — | WO | claimed |
| CN-122036912-A | Cytokine conjugates for the treatment of proliferative and infectious diseases | 辛索克斯公司 | 2026-05-15 | — | — | CN | disclosed |
| US-20260115295-A1 | IMMUNO ONCOLOGY COMBINATION THERAPY WITH IL-2 CONJUGATES AND ANTI-EGFR ANTIBODIES | Synthorx, Inc. (US) | 2026-04-30 | — | — | US | disclosed |
| EP-4725953-A1 | SELF-ASSEMBLING PEPTIDES AND HYDROGELS | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2026-04-15 | — | — | EP | disclosed |
| EP-4683671-A1 | CANCER THERAPY WITH IL-2 PEG CONJUGATES | Synthorx, Inc. (US) | 2026-01-28 | — | — | EP | disclosed |
| US-12491254-B2 | Interleukin 10 conjugates and uses thereof | Synthorx, Inc. (US) | 2025-12-09 | — | — | US | disclosed |
| EP-4637827-A1 | CANCER THERAPY WITH IL-2 CONJUGATES AND CHIMERIC ANTIGEN RECEPTOR THERAPIES | Synthorx, Inc. (US) | 2025-10-29 | — | — | EP | disclosed |
| US-20250325633-A1 | CYTOKINE CONJUGATES FOR THE TREATMENT OF AUTOIMMUNE DISEASES | Synthorx, Inc. (US) | 2025-10-23 | — | — | US | disclosed |
| EP-1797177-A2 | ADDING PHOTOREGULATED AMINO ACIDS TO THE GENETIC CODE | The Scripps Research Institute (US) | 2007-06-20 | — | — | EP | disclosed |
| WO-2006034410-A3 | ADDING PHOTOREGULATED AMINO ACIDS TO THE GENETIC CODE | SCRIPPS RESARCH INST (US) | 2006-08-03 | — | — | WO | disclosed |
| US-20060134746-A1 | Adding photoregulated amino acids to the genetic code | THE SCRIPPS RESEARCH INSTITUTE (US) | 2006-06-22 | — | — | US | disclosed |
| US-20060134746-A1 | Adding photoregulated amino acids to the genetic code | THE SCRIPPS RESEARCH INSTITUTE (US) | 2006-06-22 | — | — | US | disclosed |
| WO-2006034410-A2 | ADDING PHOTOREGULATED AMINO ACIDS TO THE GENETIC CODE | THE SCRIPPS RESARCH INSTITUTE (US) | 2006-03-30 | — | — | WO | disclosed |
| WO-2006034410-A2 | ADDING PHOTOREGULATED AMINO ACIDS TO THE GENETIC CODE | THE SCRIPPS RESARCH INSTITUTE (US) | 2006-03-30 | — | — | WO | disclosed |
| US-6265220-B1 | NON-IMMUNOCHEMICAL METHOD BY REACTING A COMPOUND COMPRISING CIS-1,4-DIOXO-2-BUTENE MOIETY OR HYDROLYTICALLY DERIVED PRECURSOR WITH HOMOCYSTEINE, THEN DETECTING PRODUCT WITHOUT SEPARATION FROM LIQUID | ULLMAN EDWIN F (US) | 2001-07-24 | — | — | US | disclosed |
| WO-2000000821-A1 | ASSAY FOR HOMOCYSTEINE | ULLMAN EDWIN F (US) | 2000-01-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12491254-B2 | Interleukin 10 conjugates and uses thereof | IL2, CCR10, IL2RA | MAOB 2819/4885ALDH1A1 294/4885HTT 2784/4885 |
| US-20250325633-A1 | CYTOKINE CONJUGATES FOR THE TREATMENT OF AUTOIMMUNE DISEASES | IL2, IL2RA, IL15 | MAOB 2683/4885ALDH1A1 642/4885HTT 1604/4885 |
| US-20060134746-A1 | Adding photoregulated amino acids to the genetic code | NSUN3, OSGEP, AARS1 | MAOB 381/4885ALDH1A1 2993/4885HTT 1247/4885 |
| US-20260115295-A1 | IMMUNO ONCOLOGY COMBINATION THERAPY WITH IL-2 CONJUGATES AND ANTI-EGFR ANTIBODIES | IL2, IL2RA, EGFR | MAOB 4623/4885ALDH1A1 4645/4885HTT 4066/4885 |
| US-20090181858-A1 | Adding photoregulated amino acids to the genetic code | NSUN3, OSGEP, AARS1 | MAOB 400/4885ALDH1A1 3004/4885HTT 1224/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.